rs11053646
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_002543.4(OLR1):c.501G>C(p.Lys167Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.102 in 1,613,828 control chromosomes in the GnomAD database, including 10,148 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.13 ( 1541 hom., cov: 32)
Exomes 𝑓: 0.099 ( 8607 hom. )
Consequence
OLR1
NM_002543.4 missense
NM_002543.4 missense
Scores
18
Clinical Significance
Conservation
PhyloP100: -0.0190
Genes affected
OLR1 (HGNC:8133): (oxidized low density lipoprotein receptor 1) This gene encodes a low density lipoprotein receptor that belongs to the C-type lectin superfamily. This gene is regulated through the cyclic AMP signaling pathway. The encoded protein binds, internalizes and degrades oxidized low-density lipoprotein. This protein may be involved in the regulation of Fas-induced apoptosis. This protein may play a role as a scavenger receptor. Mutations of this gene have been associated with atherosclerosis, risk of myocardial infarction, and may modify the risk of Alzheimer's disease. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Feb 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
?
Computational evidence support a benign effect (MetaRNN=0.001839906).
BP6
?
Variant 12-10160849-C-G is Benign according to our data. Variant chr12-10160849-C-G is described in ClinVar as [Benign]. Clinvar id is 6994.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
?
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.215 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OLR1 | NM_002543.4 | c.501G>C | p.Lys167Asn | missense_variant | 4/6 | ENST00000309539.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OLR1 | ENST00000309539.8 | c.501G>C | p.Lys167Asn | missense_variant | 4/6 | 1 | NM_002543.4 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.126 AC: 19128AN: 152050Hom.: 1539 Cov.: 32
GnomAD3 genomes
?
AF:
AC:
19128
AN:
152050
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.108 AC: 27102AN: 251394Hom.: 1922 AF XY: 0.111 AC XY: 15106AN XY: 135858
GnomAD3 exomes
AF:
AC:
27102
AN:
251394
Hom.:
AF XY:
AC XY:
15106
AN XY:
135858
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0993 AC: 145143AN: 1461660Hom.: 8607 Cov.: 33 AF XY: 0.101 AC XY: 73649AN XY: 727132
GnomAD4 exome
AF:
AC:
145143
AN:
1461660
Hom.:
Cov.:
33
AF XY:
AC XY:
73649
AN XY:
727132
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? AF: 0.126 AC: 19149AN: 152168Hom.: 1541 Cov.: 32 AF XY: 0.125 AC XY: 9333AN XY: 74398
GnomAD4 genome
?
AF:
AC:
19149
AN:
152168
Hom.:
Cov.:
32
AF XY:
AC XY:
9333
AN XY:
74398
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
340
ALSPAC
AF:
AC:
316
ESP6500AA
AF:
AC:
919
ESP6500EA
AF:
AC:
781
ExAC
?
AF:
AC:
13967
Asia WGS
AF:
AC:
658
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1Other:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
OLR1-related disorder Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 25, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Myocardial infarction, susceptibility to Other:1
risk factor, no assertion criteria provided | literature only | OMIM | Mar 28, 2003 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
Cadd
Benign
Dann
Benign
DEOGEN2
Benign
T;.;.;T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T;T;T;T;T
MetaRNN
Benign
T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;L;.;.;.
MutationTaster
Benign
P;P;P;P;P
PrimateAI
Benign
T
PROVEAN
Benign
N;N;N;N;N
REVEL
Benign
Sift
Benign
T;T;T;T;T
Sift4G
Benign
T;T;T;.;.
Polyphen
P;.;.;.;.
Vest4
MutPred
Loss of ubiquitination at K167 (P = 0.0059);Loss of ubiquitination at K167 (P = 0.0059);.;.;.;
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at